41Medical AG appears in FDA premarket records as the applicant behind K260115, the DRIM-Nail System, cleared under 21 CFR 888.3020 as an intramedullary fixation rod in Class II with product code HSB. The FDA record lists the applicant at 41medical AG with correspondence directed to a regulatory affairs contact at Mcra, LLC in Washington, District of Columbia; that filing address is not evidence of a corporate headquarters. The company's own site describes development, licensing and manufacturing work for the musculoskeletal system, with production in Switzerland, and names the DRIM-Nail and the ARRP among its products. [1][6][7][5]

The DRIM-Nail System and its FDA clearance

The DRIM-Nail System is the only product tied to a premarket filing in the available records. FDA's 510(k) database entry for K260115 carries a decision date of September 11, 2026, and the accompanying FDA letter identifies the trade name as DRIM-Nail System, the regulation as 21 CFR 888.3020 (intramedullary fixation rod), Class II, product code HSB, dated and received August 11, 2026. The letter is addressed to 41medical AG through a regulatory affairs director at Mcra, LLC. [1][6]

41medical's product page describes the DRIM-Nail as intended for minimally invasive fixation of extra-articular distal radius fractures and states that it was developed in collaboration with DISRAD, Balgrist University Hospital and the AO's Innovation Funding in Switzerland. The AO Foundation's own approved-solutions page, dated May 21, 2022, describes the device as an intramedullary nailing implant indicated for unstable A3 and A2 extraarticular fractures of the distal radius and traces its origin to a multi-partner collaboration including Disrad AG, the University of Zürich and the AO Technical Commission's Hand Expert Group. [3][8]

ARRP and the wider product line

The Acetabulum Roof Reinforcement Plate, or ARRP, appears on 41medical's products page, which states that the plate is intended to bridge an acetabular loss of stability and supports cemented acetabular cups. The downloads page lists ARRP product information, a value paper and an FAQ, alongside ISO 13485 and MDSAP certificates and a literature reference to H. Resch et al. on treatment of periprosthetic acetabular fractures. No FDA filing for the ARRP appears in the available records. [5][4]

Company scope as published

41medical describes itself as a one-stop shop for medical solutions for the human musculoskeletal system, with stated competencies in traumatology, spine, orthopedics and sports medicine, and lists development, licensing, manufacturing, MENTORA and custom-made devices among its activities. The products page states that products are developed and produced in Switzerland and that distribution may be handled independently by the customer or by 41medical, with the customer free to choose. The company page states a vision of "great products made efficiently" and describes developing, producing and marketing medical products efficiently. [7][5][9]

The company's published client description covers small and medium-sized enterprises, start-ups, clinicians and international MedTech companies from Europe, USA and Asia, and it states access to researchers, developers and physicians through a global network. These are the manufacturer's own characterizations, not independently verified attributes. No parent company, brand owner or headquarters location is confirmed in the available records; the Bettlach address appears in site contact blocks, and the Washington, District of Columbia address belongs to the FDA correspondence contact. [5][7]

What the filing record does and does not show

The linked portfolio contains one 510(k) record, K260115, with a single SESE decision; the smaller record sample likewise holds one SESE entry. These counts describe the filings retrieved as of November 20, 2026, and do not represent total company sales, total portfolio or safety performance. No recall records appear in the available data, and the absence of recalls in this collection is not a finding about device safety. [1]